6 months of Sirturo (Bedaquiline) tablets for the NIH (Notice of Intent to sole source)
SAM.GOV Due: April 21, 2025 at 03:00 PM UTC
In-Active Presolicitation Source Url

Summary

The National Institutes of Health (NIH) Clinical Center is seeking to procure 6 months' worth of Sirturo (Bedaquiline) tablets, specifically 100 mg and 20 mg formulations, for patient care in their clinical research hospital. This opportunity is a Notice of Intent to sole source, indicating that the NIH intends to negotiate exclusively with Cardinal Health, the sole distributor of Sirturo in the U.S. The contractor must be able to supply the required quantities of Sirturo tablets, which are critical for patients enrolled in NIH clinical trials. This opportunity is suitable for businesses that are authorized resellers of Sirturo and have a proven track record in pharmaceutical supply, particularly those with experience in working with government contracts.
Description

Acquisition Description:

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with Cardinal Health. This requirement will be sole sou

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
325414
Set Aside
None
Place of Performance
Maryland 20814
Point of Contact
Full Name Email Phone Type
Lu Chang [email protected] primary